New biomarkers in the risk stratification of patients with suspected acute myocardial infarction

被引：2
作者：
Rogers B.A. [1 ]
Newby L.K. [1 ]
机构：
[1] Duke Clinical Research Institute, Durham, NC 27715-7969
来源：
Current Cardiology Reports | 2002年 / 4卷 / 4期
关键词：
Acute Coronary Syndrome; Abciximab; Tirofiban; Unstable Coronary Artery Disease; Suspected Acute Myocardial Infarction;
D O I：
10.1007/s11886-002-0071-z
中图分类号：
学科分类号：
摘要：
The acute coronary syndromes (ACS) remain a diagnostic and prognostic challenge for today's physician. Over the past decade, studies have identified several serologic biomarkers to aid the clinician in assessing risk and predicting outcomes in ACS. Still others are being identified that show promise for increasing the accuracy with which this risk is assessed. However, further research remains necessary to identify the perfect cardiac biomarker or combination of markers and to define their roles in clinical management of ACS patients. © 2002 by Current Science Inc.
引用
收藏
页码：341 / 347
页数：6
相关论文
共 28 条
  • [1] Myocardial infarction redefined-a consensus statement of the joint ecs/acc committee for the redefinition of myocardial infarction, J Am Coll Cardiol, 36, pp. 959-969, (2000)
  • [2] Hamm C., Goldmann B.U., Heeschen C., Et al., Emergency room triage of patients with acute chest pain by means of rapid testing for cardiac troponin t or troponin i, N Engl J Med, 337, pp. 1648-1653, (1997)
  • [3] Ohman E.M., Armstrong P.W., Christenson R.H., Et al., For the gusto iia investigators: Cardiac troponin t levels for risk stratification in acute myocardial ischemia, N Engl J Med, 335, pp. 1333-1341, (1996)
  • [4] Antman E.M., Tanasijevic M.J., Thompson B., Et al., Cardiac-specific troponin i levels to predict the risk of mortality in patients with acute coronary syndromes, N Engl J Med, 335, pp. 1342-1349, (1996)
  • [5] Ottani F., Galvani M., Nicolini F.A., Et al., Elevated cardiac troponin levels predict the risk of adverse outcome in patients with acute coronary syndromes, Am Heart J, 140, pp. 917-927, (2000)
  • [6] Heidenreich P.A., Alloggiamento T., Melsop K., Et al., The prognostic value of troponin in patients with non-st elevation acute coronary syndromes: A meta-analysis, J Am Coll Cardiol, 38, pp. 478-485, (2001)
  • [7] Lindahl B., Venge P., Wallentin L., Troponin t identifies patients with unstable coronary artery disease who benefit from longterm antithrombotic protection, J Am Coll Cardiol, 29, pp. 43-48, (1997)
  • [8] Hamm C.W., Heeschen C., Goldmann B., Et al., Benefit of abciximab in patients with refractory unstable angina in relation to serum troponin t levels, N Engl J Med, 340, pp. 1623-1629, (1999)
  • [9] Heeschen C., Van Den Brand M.J., Hamm C.W., Simoons M.L., Angiographic findings in patients with refractory unstable angina according to troponin t status, Circulation, 100, pp. 1509-1514, (1999)
  • [10] Heeschen C., Hamm C.W., Goldmann B., Deu A., Et al., Troponin concentrations for stratification of patients with acute coronary syndromes in relation to therapeutic efficacy of tirofiban, Lancet, 354, pp. 1757-1762, (1999)
123